
Please try another search
(Reuters) - International Business Machines Corp (N:IBM) forecast full-year profit above market expectations on Tuesday after reporting surprise growth in quarterly revenue, boosted by its high-margin cloud computing business, sending its shares up more than 4%.
Over the past few years, Chief Executive Officer Ginni Rometty has been trying to shift the company's focus to the cloud through acquisitions and also by selling some of IBM's legacy businesses.
IBM bought Linux maker Red Hat Inc (NYSE:RHT) in a $34 billion deal last year, its biggest acquisition so far, in a push to expand its subscription-based software business.
Revenue from the cloud business rose 21% to $6.8 billion in the fourth quarter, its largest so far.
The company forecast an adjusted profit of at least $13.35 per share for the year, compared with estimate of $13.29.
IBM reported adjusted gross profit margin of nearly 52% for the quarter, a rise of 230 basis points, which was its largest in more than 10 years.
The company had changed its reporting structure last year – its two biggest segments now are cloud and cognitive software, and global technology services.
Revenue from the cloud and cognitive software segment, which includes Red Hat, rose 8.7% to $7.2 billion in the fourth quarter ended Dec. 31.
IBM has said that it would report only a portion of Red Hat's actual revenue for some quarters, while recording all its expenses as required by U.S. accounting standards.
The global technology services segment, which caters to some of the world's largest data centers, reported $6.9 billion of revenue, down 4.8% from the previous year.
IBM recorded a marginal increase of 0.1% in overall revenue to $21.78 billion in the quarter, its first rise in six quarters. Analysts on average had expected a drop of nearly 1%, according to IBES data from Refinitiv.
Rometty said IBM is positioned for sustained revenue growth in 2020.
Excluding special items, it earned $4.71 per share, above analysts' expectation of $4.69.
By Richa Naidu LONDON (Reuters) - Danone SA (OTC:DANOY) on Wednesday said it has been doubling shipments to the United States of Neocate formula for infants allergic to cow's...
By Michael Erman (Reuters) - Pfizer Inc (NYSE:PFE) will make all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance...
LONDON (Reuters) -British retailer Marks & Spencer (OTC:MAKSY) joined rivals in warning on the outlook for the current year amid a worsening cost-of-living crunch, taking the...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.